These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 38180245)

  • 81. circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in small cell lung cancer.
    Tolomeo D; Traversa D; Venuto S; Ebbesen KK; García Rodríguez JL; Tamma G; Ranieri M; Simonetti G; Ghetti M; Paganelli M; Visci G; Liso A; Kok K; Muscarella LA; Fabrizio FP; Frassanito MA; Lamanuzzi A; Saltarella I; Solimando AG; Fatica A; Ianniello Z; Marsano RM; Palazzo A; Azzariti A; Longo V; Tommasi S; Galetta D; Catino A; Zito A; Mazza T; Napoli A; Martinelli G; Kjems J; Kristensen LS; Vacca A; Storlazzi CT
    Genes Chromosomes Cancer; 2023 Jul; 62(7):377-391. PubMed ID: 36562080
    [TBL] [Abstract][Full Text] [Related]  

  • 82. NEUROD1 is highly expressed in extensive-disease small cell lung cancer and promotes tumor cell migration.
    Ikematsu Y; Tanaka K; Toyokawa G; Ijichi K; Ando N; Yoneshima Y; Iwama E; Inoue H; Tagawa T; Nakanishi Y; Okamoto I
    Lung Cancer; 2020 Aug; 146():97-104. PubMed ID: 32526603
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors.
    Medina PP; Carretero J; Fraga MF; Esteller M; Sidransky D; Sanchez-Cespedes M
    Genes Chromosomes Cancer; 2004 Oct; 41(2):170-7. PubMed ID: 15287030
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Perspectives and Issues in the Assessment of
    Armon S; Hofman P; Ilié M
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440689
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Significance of achaete-scute complex homologue 1 (ASCL1) in pulmonary neuroendocrine carcinomas; RNA sequence analyses using small cell lung cancer cells and Ascl1-induced pulmonary neuroendocrine carcinoma cells.
    Kudoh S; Tenjin Y; Kameyama H; Ichimura T; Yamada T; Matsuo A; Kudo N; Sato Y; Ito T
    Histochem Cell Biol; 2020 Jun; 153(6):443-456. PubMed ID: 32170367
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Real-World comprehensive genomic profiling data for diagnostic clarity in pulmonary Large-Cell neuroendocrine carcinoma.
    Burns L; Tukachinsky H; Raskina K; Huang RSP; Schrock AB; Sands J; Kulke MH; Oxnard GR; Tapan U
    Lung Cancer; 2024 Feb; 188():107454. PubMed ID: 38159439
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Targeting the mSWI/SNF complex in POU2F-POU2AF transcription factor-driven malignancies.
    He T; Xiao L; Qiao Y; Klingbeil O; Young E; Wu XS; Mannan R; Mahapatra S; Redin E; Cho H; Bao Y; Kandarpa M; Ching-Yi Tien J; Wang X; Eyunni S; Zheng Y; Kim N; Zheng H; Hou S; Su F; Miner SJ; Mehra R; Cao X; Abbineni C; Samajdar S; Ramachandra M; Dhanasekaran SM; Talpaz M; Parolia A; Rudin CM; Vakoc CR; Chinnaiyan AM
    Cancer Cell; 2024 Aug; 42(8):1336-1351.e9. PubMed ID: 39029462
    [TBL] [Abstract][Full Text] [Related]  

  • 88. COPB2 promotes cell proliferation and tumorigenesis through up-regulating YAP1 expression in lung adenocarcinoma cells.
    Pu X; Wang J; Li W; Fan W; Wang L; Mao Y; Yang S; Liu S; Xu J; Lv Z; Xu L; Shu Y
    Biomed Pharmacother; 2018 Jul; 103():373-380. PubMed ID: 29674272
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Potential subtype-specific therapeutic approaches in small cell lung cancer.
    Horvath L; Lang C; Boettiger K; Aigner C; Dome B; Megyesfalvi Z
    Curr Opin Oncol; 2024 Jan; 36(1):51-56. PubMed ID: 37865844
    [TBL] [Abstract][Full Text] [Related]  

  • 90. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
    He W; Zhang Y; Xia S
    Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Clinicopathological features and prognosis of SMARCA4-deficient non-small cell lung carcinoma: an analysis of 127 cases].
    Li SL; Wu CY; Zhang LP; Huang Y; Wu W; Zhang W; Hou LK
    Zhonghua Bing Li Xue Za Zhi; 2023 Jul; 52(7):665-670. PubMed ID: 37408395
    [No Abstract]   [Full Text] [Related]  

  • 92. Thoracic SMARCA4-deficient undifferentiated tumor: current knowledge and future perspectives.
    Shinno Y; Ohe Y;
    Jpn J Clin Oncol; 2024 Mar; 54(3):265-270. PubMed ID: 38117955
    [TBL] [Abstract][Full Text] [Related]  

  • 93. MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCs.
    Du L; Schageman JJ; Irnov ; Girard L; Hammond SM; Minna JD; Gazdar AF; Pertsemlidis A
    J Exp Clin Cancer Res; 2010 Jun; 29(1):75. PubMed ID: 20624269
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Small cells - big issues: biological implications and preclinical advancements in small cell lung cancer.
    Solta A; Ernhofer B; Boettiger K; Megyesfalvi Z; Heeke S; Hoda MA; Lang C; Aigner C; Hirsch FR; Schelch K; Döme B
    Mol Cancer; 2024 Feb; 23(1):41. PubMed ID: 38395864
    [TBL] [Abstract][Full Text] [Related]  

  • 95. SMARCA4-deficient pulmonary adenocarcinoma: clinicopathological, immunohistochemical, and molecular characteristics of a novel aggressive neoplasm with a consistent TTF1
    Agaimy A; Fuchs F; Moskalev EA; Sirbu H; Hartmann A; Haller F
    Virchows Arch; 2017 Nov; 471(5):599-609. PubMed ID: 28555282
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
    Wang WN; Liu XT; Liang YM
    Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
    [No Abstract]   [Full Text] [Related]  

  • 97. [Analysis of Clinicopathologic Features of 9 Cases of 
SMARCA4-deficient Non-small Cell Lung Cancer].
    Zhao R; Zou Y; Chen H; Chen Y; Liu Y; He M
    Zhongguo Fei Ai Za Zhi; 2022 Aug; 25(8):575-582. PubMed ID: 36002194
    [TBL] [Abstract][Full Text] [Related]  

  • 98. An aggressive case of a thoracic undifferentiated SMARCA4-deficient tumor with extensive pleural involvement.
    Hanona PF; Ezekwudo D; Fullmer J; Allen T; Jaiyesimi I
    Thorac Cancer; 2024 Apr; 15(10):847-851. PubMed ID: 38390699
    [TBL] [Abstract][Full Text] [Related]  

  • 99. ASXL3 bridges BRD4 to BAP1 complex and governs enhancer activity in small cell lung cancer.
    Szczepanski AP; Zhao Z; Sosnowski T; Goo YA; Bartom ET; Wang L
    Genome Med; 2020 Jul; 12(1):63. PubMed ID: 32669118
    [TBL] [Abstract][Full Text] [Related]  

  • 100. An integrative transcriptome analysis reveals a functional role for thyroid transcription factor-1 in small cell lung cancer.
    Horie M; Miyashita N; Mattsson JSM; Mikami Y; Sandelin M; Brunnström H; Micke P; Nagase T; Saito A
    J Pathol; 2018 Oct; 246(2):154-165. PubMed ID: 29876935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.